ASMB — Assembly Biosciences Share News
0.000.00%
Last trade - 00:00- $403.95m
- $83.59m
- $72.30m
Brief: Assembly Biosciences Files For Common Stock Offering Of Up To $75 Million - SEC Filing
Assembly Biosciences Inc expected to post a loss of $2.02 a share - Earnings Preview
Brief: Assembly Biosciences Reports Positive Interim Phase 1A Results From Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366
U.S. RESEARCH ROUNDUP- Factset, FedEx, Thermo Fisher Scientific
Assembly Biosciences Inc reports results for the quarter ended in January - Earnings Summary
Assembly Biosciences Inc expected to post a loss of $2.23 a share - Earnings Preview
Brief: Assembly Biosciences Doses First Participant In Phase 1B Clinical Trial Testing Abi-4334 For The Treatment Of Chronic Hepatitis B Virus Infection
Brief: Assembly Biosciences Announces $12.6 Million In Equity Financings
Brief: Assembly Biosciences Doses First Participant In Phase 1A/B Clinical Trial Of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366
Advisory: Alert incorrectly tagged to Assembly Biosciences withdrawn
Assembly Biosciences Inc expected to post a loss of $3.23 a share - Earnings Preview
Assembly Biosciences Inc reports results for the quarter ended in December - Earnings Summary
Assembly Biosciences Inc expected to post a loss of $2.88 a share - Earnings Preview
Brief: Assembly Biosciences Announces Effective Date Of Reverse Stock Split
Brief: Assembly Biosciences Says Co Notified Indiana University That It Decided To Terminate Exclusive License Agreement
Brief: Assembly Biosciences Inc By Mid-Year 2024 Abi-5366, Is Expected To Enter A First-In-Human Clinical Study
Brief: Assembly Biosciences Appoints Tomas Cihlar To Serve On Board
Brief: Assembly Biosciences Q3 EPS USD -0.27
Assembly Biosciences Inc expected to post a loss of 23 cents a share - Earnings Preview